EVolution in ALS diagnosis: molecular markers in extracellular vesicles

Area of Science:

• Neuroscience
• Biochemistry
• Biomarker Discovery

Background:

• Identifying reliable biomarkers for amyotrophic lateral sclerosis (ALS) is crucial for disease management.
• Current diagnostic and monitoring methods for ALS require improvement.

Purpose of the Study:

• To evaluate the potential of blood extracellular vesicles (EVs) as biomarkers for ALS.
• To assess the correlation between transactive response DNA-binding protein 43 (TDP-43) levels in EVs and ALS patient status and severity.

Main Methods:

• Analysis of extracellular vesicles (EVs) isolated from blood samples.
• Quantification of transactive response DNA-binding protein 43 (TDP-43) levels within EVs.
• Comparison of TDP-43 levels in EVs between ALS patients and healthy controls.

Main Results:

• Elevated levels of transactive response DNA-binding protein 43 (TDP-43) were found in blood extracellular vesicles (EVs) of ALS patients.
• TDP-43 levels in EVs accurately distinguished ALS patients from controls.
• TDP-43 levels in EVs correlated with ALS disease severity.

Conclusions:

• Blood extracellular vesicles (EVs) expressing high levels of TDP-43 represent a promising biomarker for amyotrophic lateral sclerosis (ALS).
• This biomarker shows potential for early diagnosis and monitoring of ALS progression.